Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

AstraZeneca · Phase 2 · Completed · Enrollment 177

NCT00392925

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebo and Metreleptinn/rn/rn/rn/rn/r
Pramlintide Acetate and Placebo7 participants2 participants0 participantsn/rn/r
Pramlintide Acetate and Metreleptinn/rn/rn/rn/rn/r
Lead-In Period10 participants3 participants2 participantsn/rn/r

A count stays a count. This page does not turn a count into a percent.